Health Canada authorizes updated Pfizer-BioNTech COVID vaccine

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine
A nurse administers a Pfizer COVID-19 booster vaccine in Jackson, Miss., Friday, Nov. 18, 2022.

Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

SEE ALSO: COVID-19 numbers spike in B.C. but no more cases of new variant are detected

Earlier this month, Health Canada authorized Moderna’s updated mRNA vaccine.

Both Pfizer and Moderna’s shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration in people 12 years of age and older.

This report by The Canadian Press was first published Sept. 28, 2023.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian PressThe Canadian Press

Recent Stories

Send us your news tips and videos!